The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Prevalence of Hypertrophic Cardiomyopathy in a General Population of Young Adults: Echocardiographic Analysis of 4111 Subjects in the CARDIA Study
Abstract
Background Hypertrophic cardiomyopathy (HCM) is a genetically transmitted disease and an important cause of morbidity and sudden cardiac death in young people, including competitive athletes. At present, however, few data exist to estimate the prevalence of this disease in large populations. Methods and Results As part of the Coronary Artery Risk Development in (Young) Adults (CARDIA) Study, an epidemiological study of coronary risk factors, 4111 men and women 23 to 35 years of age selected from the general population of four urban centers had technically satisfactory echocardiographic studies during 1987 through 1988. Probable or definite echocardiographic evidence of HCM was present in 7 subjects (0.17%) on the basis of identification of a hypertrophied, nondilated left ventricle and maximal wall thickness ≥15 mm that were not associated with systemic hypertension. Prevalence in men and women was 0.26:0.09%; in blacks and whites, 0.24:0.10%. Ventricular septal thickness was 15 to 21 mm (mean, 17 mm) in the 7 subjects. Only 1 of the 7 subjects had ever experienced important cardiac symptoms attributable to HCM, had previously been suspected of having cardiovascular disease, or had obstruction to left ventricular outflow; 4 other subjects had relatively mild systolic anterior motion of the mitral valve that was insufficient to produce dynamic basal outflow obstruction. ECGs were abnormal in 5 of the 7 subjects. Five other study subjects had left ventricular wall thicknesses of 15 to 21 mm that were a consequence of systemic hypertension. Conclusions HCM was present in about 2 of 1000 young adults. These unique population-based data will aid in assessments of the impact of HCM-related mortality and morbidity in the general population and the practicality of screening large populations for HCM, including those comprising competitive athletes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sahn, D. J., DeMaria, A., Kisslo, J., & Weyman, A. (1978) · Circulation · doi:10.1161/01.cir.58.6.1072 · Cited by 7,430
Cardia: study design, recruitment, and some characteristics of the examined subjects
Friedman, G. D., Cutter, G. R., Donahue, R. P., Hughes, G. H., Hulley, S. B., Jacobs, D. R., Liu, K., & Savage, P. J. (1988) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(88)90080-7 · Cited by 1,687
ASYMMETRICAL HYPERTROPHY OF THE HEART IN YOUNG ADULTS
Teare, D. (1958) · Heart · doi:10.1136/hrt.20.1.1 · Cited by 1,081
Maron, B. J., Bonow, R. O., Cannon, R. O., Leon, M. B., & Epstein, S. E. (1987) · New England Journal of Medicine · doi:10.1056/nejm198703263161305 · Cited by 896
Self-citationSudden death in young athletes.
Maron, B. J., Roberts, W. C., McAllister, H. A., Rosing, D. R., & Epstein, S. E. (1980) · Circulation · doi:10.1161/01.cir.62.2.218 · Cited by 836
Self-citationHypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review
Wigle, E. D., Sasson, Z., Henderson, M. A., Ruddy, T. D., Fulop, J., Rakowski, H., & Williams, W. G. (1985) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(85)90024-6 · Cited by 823
BRAUNWALD, E., LAMBREW, C. T., ROCKOFF, S. D., ROSS, J., & MORROW, A. G. (1964) · Circulation · doi:10.1161/01.cir.29.5s4.iv-3 · Cited by 758
Watkins, H., Rosenzweig, A., Hwang, D.-S., Levi, T., McKenna, W., Seidman, C. E., & Seidman, J. G. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204233261703 · Cited by 747
FRANK, S., & BRAUNWALD, E. (1968) · Circulation · doi:10.1161/01.cir.37.5.759 · Cited by 660
Codd, M. B., Sugrue, D. D., Gersh, B. J., & Melton, L. J. (1989) · Circulation · doi:10.1161/01.cir.80.3.564 · Cited by 640
Cited by
Items 101–109 of 109
Cardiomyopathy in α-Kinase 3 (ALPK3)-Deficient Mice
Van Sligtenhorst, I., Ding, Z.-M., Shi, Z.-Z., Read, R. W., Hansen, G., & Vogel, P. (2012) · Veterinary Pathology · doi:10.1177/0300985811402841 · Cited by 48
Siontis, K. C., Wieczorek, M. A., Maanja, M., Hodge, D. O., Kim, H.-K., Lee, H.-J., Lee, H., Lim, J., Park, C. S., Ariga, R., et al. (2024) · European Heart Journal - Digital Health · doi:10.1093/ehjdh/ztae029 · Cited by 44
Cardiac Myosin Inhibitors for Managing Obstructive Hypertrophic Cardiomyopathy
Ostrominski, J. W., Guo, R., Elliott, P. M., & Ho, C. Y. (2023) · JACC: Heart Failure · doi:10.1016/j.jchf.2023.04.018 · Cited by 42
Bai, Y., Zheng, J.-P., Lu, F., Zhang, X.-L., Sun, C.-P., Guo, W.-H., Zou, Y.-X., Lip, G. Y. H., & Shi, X.-B. (2022) · Scientific Reports · doi:10.1038/s41598-022-20042-9 · Cited by 41
Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
Liebregts, M., Vriesendorp, P. A., & ten Berg, J. M. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.02.080 · Cited by 40
Sudden Cardiac Death in Athletes
Link, M. S., & Mark Estes, N. A. (2008) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2007.10.002 · Cited by 26
Desai, M. Y., Jadam, S., Abusafia, M., Rutkowski, K., Ospina, S., Gaballa, A., Sultana, S., Thamilarasan, M., Xu, B., & Popovic, Z. B. (2025) · JACC: Clinical Electrophysiology · doi:10.1016/j.jacep.2025.02.024 · Cited by 19
Recommendations and cardiological evaluation of athletes with arrhythmias: Part 1.
(2004) · PubMed Central · Cited by 15
Prevalence and clinical implications of sleep apnea in hypertrophic cardiomyopathy
Karim, S., Chahal, A., Venkataraman, S., Deshmukh, A. J., Siontis, K. C., Mansukhani, M., Konecny, T., Khanji, M. Y., Petersen, S. E., Gersh, B. J., et al. (2025) · JAMA Cardiology · doi:10.1001/jamacardio.2025.2877 · Cited by 10
Metadata
- Authors
- Maron, B. J., Gardin, J. M., Flack, J. M., Gidding, S. S., Kurosaki, T. T., & Bild, D. E.
- Venue
- Circulation
- Published
- 1995-08-15
- Volume
- 92
- Issue
- 4
- Pages
- 785-789
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2149422196
- Cited by
- 2,275
- References
- 37
- FWCI
- 14.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.